Lupin informs about press release

10 Mar 2021 Evaluate

Lupin has informed that it has enclosed press release on 10th March 2021 as regards launch of the authorized generic version of Alinia (nitazoxanide) Tablets, 500 mg of Romark Laboratories, L.C. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2119.50 -31.55 (-1.47%)
01-Feb-2026 13:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.50
Dr. Reddys Lab 1220.00
Cipla 1315.25
Zydus Lifesciences 883.80
Lupin 2119.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×